SUTUREGARD Medical, Inc.

SUTUREGARD Medical, Inc. manufactures advanced suture retention devices designed to prevent and manage wound dehiscence in high-tension surgical closures. The company's flagship product is the Adhesive Suture Retention Device (ASRD), which dynamically offloads tension on surgical incisions while preserving blood perfusion to skin edges. Clinical evidence demonstrates an 80% reduction in wound dehiscence versus standard layered closure across three separate studies. The ASRD is indicated for use in foot and ankle surgery (amputations, ORIF, total ankle replacement, Achilles repair), orthopedic procedures (revisional TKA, open spine, trauma), general surgery (challenging closures, amputations), vascular surgery (open cases, amputations), plastic surgery (breast reduction, body contouring, scar revision), and dermatology (Mohs, melanoma). The company also offers HEMIGARD Interlock, a complementary system for complex wound closure. Intraoperative benefits include fast application, precise skin edge approximation, and reduced need for delayed closures or flaps. Postoperative benefits include tension dispersal, maintained microcirculation, accommodation of post-surgical edema, and reduced blistering. SUTUREGARD was recognized by MedTech Innovator as one of the top 50 medical device companies in 2022. The company provides comprehensive clinical support including instructional videos, case studies, digital illustrations, reimbursement guidance, and wound care protocols. Products are sold to surgeons and surgical facilities across multiple specialties.